Clinical Trial Update: A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) [Phase 3]

View source ↗

Summary

Phase 3 trial of ProQuad in healthy children completed; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• ProQuad (Measles, Mumps, Rubella and Varicella live attenuated vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Measles, Mumps | Phase 3 | Status: COMPLETED | Results posted: 2010-01-29